Aedifica reports 1H25 results in line with our estimates at EUR 123.3m EPRA earnings vs EUR 122.2m KBCSe. It confirms its outlook at EUR 5.01 EPRA EPS despite being slightly ahead of its guidance. YTD (30/07) Aedifica refuelled its development pipeline at 6.5% YoC by EUR 84m (Finland, UK) and divested EUR 121m (32 properties, mainly Sweden), completed EUR 66m projects and did one acquisition of EUR 37.5m. The eyes of the market are on the potential Aedifica/Cofinimmo combination. It is largely s...
Aedifica: Strong results, guidance reiterated; dsm-firmenich: Symrise 1H25 results; IMCD: Stagnating gross profit leads to disappointing 2Q25 EBITA; JDE Peet's: Full of beans; Just Eat Takeaway: 1H25 results, weak update no impact on takeover; Lotus Bakeries: Peer Mondelez 1Q25 results; Melexis: 2Q25 results, gross margin under pressure; Solvay: 2Q25 in line, subdued outlook no surprise after pre-release; TKH Group: Preview: Under a magnifying glass; Universal Music Group: Spotify 2Q25 ...
Aedifica NV/SA: 2025 half year financial report Please find below Aedifica’s 2025 half year financial report. Robust operational performance driving strong results EPRA Earnings* amounted to €123.3 million (+4% compared to 30 June 2024), or €2.59/shareRental income increased to €180.8 million (+9% compared to 30 June 2024)3.0% increase in rental income on a like-for-like basis in the first half of the yearWeighted average unexpired lease term of 18 years and occupancy rate of 100% Real estate portfolio* of nearly €6.2 billion as at 30 June 2025 613 healthcare properties for 48,600 end u...
MaaT announced that it has secured a € 37.5m , 4-tranche financing from the European Investment Bank (EIB), which bears interest at 7%. In addition, MaaT will issue warrants to the EIB with each tranche. MaaT's previously communicated cash runway was into January 2026, which should now extend beyond that point following this additional funding, though we do note that disbursement of Tranches B to D is subject to operational and financing conditions, which we'd be keen to learn more about. All in...
Akzo Nobel: FX drives 2Q25 miss and FY guidance cut. dsm-firmenich: Givaudan 1H25 results. Exor: In talks over Iveco sale. Lotus Bakeries: Peer Lindt & Sprüngli 1H25 results. Proximus: CpaaS peer Sinch 2Q25 results hurt by FX. Signify: 2Q25 Preview, challenges ahead. Var Energi: Promising continuation of dividend. Vopak: Continued story. Wereldhave: Strong operational results, positive market tone, guidance raised. Events Calendar
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.